These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28233302)

  • 21. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
    Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
    Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GFI1 promotes the proliferation and migration of esophageal squamous cell carcinoma cells through the inhibition of SOCS1 expression.
    Huang Y; Ruan R; Fang Y; Wu K; Yao L; Zhang R; He W
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
    Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
    PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling.
    Feng Y; Ke C; Tang Q; Dong H; Zheng X; Lin W; Ke J; Huang J; Yeung SC; Zhang H
    Cell Death Dis; 2014 Feb; 5(2):e1088. PubMed ID: 24577086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
    Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
    Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.
    Harada E; Serada S; Fujimoto M; Takahashi Y; Takahashi T; Hara H; Nakatsuka R; Sugase T; Nishigaki T; Saito Y; Hiramatsu K; Nojima S; Mitsuo R; Ohkawara T; Morii E; Mori M; Doki Y; Kaneda Y; Naka T
    Oncotarget; 2017 Apr; 8(15):24741-24752. PubMed ID: 28445969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.
    Ren G; Sheng L; Liu H; Sun Y; An Y; Li Y
    Med Oncol; 2015 Jul; 32(7):209. PubMed ID: 26099172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines.
    Fukuoka S; Kojima T; Koga Y; Yamauchi M; Komatsu M; Komatsuzaki R; Sasaki H; Yasunaga M; Matsumura Y; Doi T; Ohtsu A
    Oncotarget; 2017 Feb; 8(7):11020-11029. PubMed ID: 28038457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
    Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
    Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways.
    Song K; Ma C; Maswikiti EP; Gu B; Wang B; Wang N; Jiang P; Chen H
    Mol Carcinog; 2024 Oct; 63(10):1892-1906. PubMed ID: 38923019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
    Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G
    Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer.
    Zhang H; Zhao JH; Suo ZM
    Biomed Pharmacother; 2017 Feb; 86():149-154. PubMed ID: 27960137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.